167 related articles for article (PubMed ID: 19814782)
1. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
Barba M; Yang L; Schünemann HJ; Sperati F; Grioni S; Stranges S; Westerlind KC; Blandino G; Gallucci M; Lauria R; Malorni L; Muti P
J Exp Clin Cancer Res; 2009 Oct; 28(1):135. PubMed ID: 19814782
[TBL] [Abstract][Full Text] [Related]
2. Urinary estrogen metabolites and prostate cancer: a case-control study in the United States.
Muti P; Westerlind K; Wu T; Grimaldi T; De Berry J; Schünemann H; Freudenheim JL; Hill H; Carruba G; Bradlow L
Cancer Causes Control; 2002 Dec; 13(10):947-55. PubMed ID: 12588091
[TBL] [Abstract][Full Text] [Related]
3. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
5. Estrogen metabolites and the risk of breast cancer in older women.
Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
[TBL] [Abstract][Full Text] [Related]
6. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
7. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.
Arslan AA; Koenig KL; Lenner P; Afanasyeva Y; Shore RE; Chen Y; Lundin E; Toniolo P; Hallmans G; Zeleniuch-Jacquotte A
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1290-7. PubMed ID: 24769889
[TBL] [Abstract][Full Text] [Related]
8. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
[TBL] [Abstract][Full Text] [Related]
9. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
[TBL] [Abstract][Full Text] [Related]
10. Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina.
Teas J; Cunningham JE; Fowke JH; Nitcheva D; Kanwat CP; Boulware RJ; Sepkovic DW; Hurley TG; Hebert JR
Cancer Detect Prev; 2005; 29(6):494-500. PubMed ID: 16289388
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.
Zeleniuch-Jacquotte A; Shore RE; Afanasyeva Y; Lukanova A; Sieri S; Koenig KL; Idahl A; Krogh V; Liu M; Ohlson N; Muti P; Arslan AA; Lenner P; Berrino F; Hallmans G; Toniolo P; Lundin E
Br J Cancer; 2011 Oct; 105(9):1458-64. PubMed ID: 21952628
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial.
Mackey RH; Fanelli TJ; Modugno F; Cauley JA; McTigue KM; Brooks MM; Chlebowski RT; Manson JE; Klug TL; Kip KE; Curb JD; Kuller LH
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2022-32. PubMed ID: 22933427
[TBL] [Abstract][Full Text] [Related]
13. Estrogen metabolism as a risk factor for head and neck cancer.
Yoo HJ; Sepkovic DW; Bradlow HL; Yu GP; Sirilian HV; Schantz SP
Otolaryngol Head Neck Surg; 2001 Mar; 124(3):241-7. PubMed ID: 11240983
[TBL] [Abstract][Full Text] [Related]
14. Within-person variability of the ratios of urinary 2-hydroxyestrone to 16alpha-hydroxyestrone in Caucasian women.
Chen Z; Zheng W; Dunning LM; Anderson KG; Parrish RS; Holtzman JL
Steroids; 1999 Dec; 64(12):856-9. PubMed ID: 10576221
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense
Green T; See J; Schauch M; Reil J; Glover M; Brix J; Gerry A; Li K; Newman M; Gahler RJ; Wood S
J Complement Integr Med; 2023 Mar; 20(1):199-206. PubMed ID: 36201753
[TBL] [Abstract][Full Text] [Related]
16. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
Bentz AT; Schneider CM; Westerlind KC
Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
[TBL] [Abstract][Full Text] [Related]
17. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
[TBL] [Abstract][Full Text] [Related]
18. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2-hydroxyestrone ratio in C3H/HeJ mice.
Kishida T; Beppu M; Nashiki K; Izumi T; Ebihara K
Nutr Cancer; 2000; 38(2):209-14. PubMed ID: 11525599
[TBL] [Abstract][Full Text] [Related]
20. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
